Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

P
Paal V. - Prolonged prophylaxis with the low molecular weight heparin certoparin reduces the rate of venous thromboembolism after orthopedic surgery
Pabinger I. - IgG-antibodies (IgG-Ab) against beta-2-glycoprotein I (b2-GPI) are associated with an increased risk for thrombotic events (TE) in patients (pts) with the lupus anticoagulant (LA)
  - Incidence of venous thrombosis in carriers of familial thrombophilia with a personal history of venous thrombosis
  - Is inflammation involved in the development of thrombosis in patients with the lupus anticoagulant?
  - Epidermiology and anti-inflammatory mechanism - Differential diagnosis of thrombotic conditions
  - C-reactive protein in patients with venous thromboembolism
Paccamiccio E. - Oral anti-coagulant therapy with POC device and remote computer monitoring in the setting of the Italian National Health System (INHS)
Pacejka M. - Risk of venous thromboembolism during pregnancy and puerperium in women with homozygous form of F V Leiden
Packham M. A. - Senescent rabbit platelets, or rabbit platelets with experimentally shortened survival, are apoptotic with increased surface exposure of procoagulant phosphatidylserine (PS)
Padeletti L. - Angiotensin converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation
Padmanabhan K. - Crystal structure of benzamidine-Factor VIIa/soluble tissue factor at 1.87 Å resolution: mapping of calcium, magnesium, sodium, and zinc sites in the Factor VIIa structure
Padrini R. - Type Vicenza Arg1205His mutation alone induces reduction in the level and survival of von Willebrand factor
Padro T. - Overexpression of basic fibroblast growth factor (bFGF) in the bone marrow of patients with acute myeloid leukemia: a potential role for bFGF as an autocrine growth factor
Paes B. - Effect of protein binding on the anti-FXa activity of different heparinoids in either adult or newborn plasma
Paffen E. - C-Reactive protein (CRP) is not a strong inducer of tissue factor in human monocytes
Paganini A. - Preconceptional and gestational enoxaparin regimes adjusted to fertility program to prevent preclinical, embryonic and fetal loss in women with Recurrent Pregnancy Loss (RPL) and thrombophilia
Page N. M. - Evidence for a role of tachykinins in the regulation of human platelet activation
Page C. P. - Platelet depletion abolishes eosinophil recruitment to the lungs and tissue remodelling in an allergic asthma model in mice
Pagilara V. - Management of oral anticoagulant therapy in the perioperative period: preliminary results of the application of an operative protocol
Pagliaricci S. - Activation of blood coagulation in patients undergoing perioperative blood salvage and reinfusion of no-washed whole blood after total knee arthroplasty
Paiement G. - Evaluating bleeding complications of thromboprophylaxis after hip replacement: a systematic review
  - Randomized, double-blind comparison of ximelagatran, an oral direct thrombin inhibitor, and warfarin to prevent venous thromboembolism (VTE) after total knee replacement (TKR)
Painter C. A. - Chronic paclitaxel exposure increases human endothelial expression of plasminogen activator inhibitor-1, tissue-type plasminogen activator and tissue inhibitor of metalloproteinase-1
Pajdak W. - Comparison of fibrinogen and S2238 as substrates for the study of multiple, active thrombin forms in the process of plasma clotting
Pajkrt D. - Alterations in lipoprotein homeostasis during experimental and clinical sepsis in primates
Palafox-Sanchez C. - OxiLDL/b2GPI complexes are frequent in SLE whereas autoantibodies to oxLig-1/b2GPI are more prevalent in patients with antiphospholipid syndrome
Palareti G. - Markers of inflammation, d-dimer and recurrences after a first episode of venous thromboembolism
Palareti G. - Genetic variants of CYP2C9 cytochrome do not account for high intraindividual variability of patients in their response to oral anti-coagulants (OA): a collaborative controlled study
Palareti G. - Thrombophilia and residual vein thrombosis are independent risk factors for recurrent venous thromboembolism
  - D-dimer and residual vein thrombosis assessed at 3 months after anti-coagulation withdrawal are independent risk factors for recurrent venous thromboembolism
  - Emotional impact of testing for inherited thrombophilia
  - The risk of recurrence after a first episode of venous thromboembolism in cancer patients
  - Venous thromboembolic complications in patients with multiple myeloma treated with thalidomide:prophylatic effect of fixed dose Wafarin L
  - Incidence of venous thrombosis in carriers of familial thrombophilia with a personal history of venous thrombosis
  - Risk for recurrent venous thromboembolism among patients with severe inherited thrombophilia
  - Risk of recurrence of venous thromboembolism (VTE) and high factor VIII plasma levels
  - Comparative evaluation of a new automated latex agglutination d-dimer assay for exclusion of deep vein thrombosis
Palareti G. - Predicting the risk of thromboembolic recurrences: the value of D-dimer
Palla R. - A 3' untranslated region (3' UTR) variation on the factor VII (FVII) gene changes completely the phenotype due to the Arg277Cys mutation in a patient with Type I FVII deficiency
Palmarini M.G.F. - Assessment of platelet function during cardiopulmonary bypass using two new "point of care" devices
Palmer R.J. - Regulation of plasminogen gene expression by nerve growth factor (NGF)
Palmer I. I. I. - Bovine heparin results in higher generation of functional anti-heparin-PF4 antibodies than porcine heparin following coronary artery bypass surgery
Palmieri P. N. - Objective assessment of deep vein thrombosis and pulmonary embolism can be deferred without increased risk of thrombosis: a practical approach based on the pretest clinical model, d-dimer and the use of low molecular weight heparins
Pampaloni F. - Effects of HRT with estradiolvalerate 2-mg + levonorgestrel 75 µg (NUVELLE®) on clotting and lipid profile
Pampolina C. - Streptococcus sanguis-induced platelet signal transduction pathways involve both ITAMs and ITIMs
Pamuklar Z. - Lipid Phosphate Phosphatase 1 (LPP1) regulates lysophosphatidic acid signaling in platelets
Panchenko E. - The effect of clopidogrel on walking distance and hemostasis in patients with intermittent claudication
  - Efficacy of 1-year acenocumarol therapy and its relation with gene polymorphism related to thrombophilia in patients with nonvalvular atrial fibrillation
Pandey R. - Clinicopathological findings and response to treatment in childhood and adult immune thrombocytopenic purpura
Pandey D. - Analysis of the Rho-kinase/LIM-kinase/cofilin signaling pathway in activated platelets
Pandolfi A. - NAD(P)H oxidase C242T gene variations and cardiovascular protection
  - Insulin enhances vascular cell adhesion molecule (VCAM-1) expression in human cultured endothelial cells – a link to the pathogenesis of accelerated atherosclerosis in diabetes
Panes O. - Comparison of template bleeding time and PFA-100 as screening tests in 175 consecutive patients with hereditary mucocutaneous hemorrhages (MCH)
  - Patients with mild hereditary bleeding disorders have normal thrombin generation (TGPPP) in platelet poor plasma
Panfilov S. - Efficacy and safety of the treatment regimen of melagatran and ximelagatran for prevention of thromboembolic events after total hip or knee replacement: a meta-analysis of 3 randomized, double-blind studies, to evaluate the influence of time and dose
Paniccia R. - Evaluation of the fibrinolytic capacity before and after venous occlusion performed by serum d-dimer test after standardized coagulation
  - Assessment of platelet function during cardiopulmonary bypass using two new "point of care" devices
Paniccia R. - Monitoring of heparin therapy during cardiopulmonary bypass by using three different devices that measure the activated clotting time
  - Monitoring of heparin therapy during cardiopulmonary bypass by using three different devices that measure the activated clotting time
Paniccia R. - Homocysteine plasma levels in primary biliary cirrhosis (PBC)
  - Hemostatic changes in laparoscopic and laparotomic gynecological surgery
Panizzi P. R. - Mechanisms of conformational activation of prothrombin by staphylocoagulase and fibrinogen substrate recognition
Pannier-Fischer M. - Treatment of thrombotic complications and prophylactic use of protein C concentrate in two homozygous protein C deficient patients during surgery
Panotopoulos J. - Total knee arthroplasty in hemophilic arthropathy
Panshina A. M. - The prevalence of polymorphism PlA2 of platelet glycoprotein IIb-IIIa in the population of North-west Russia
Panteleev M.A. - The mechanism of action of high-dose factor VIIa in preventing bleeding in hemophilia. Computational simulation studies
Panteleev M. - Kinetics of factor X activation by membrane-bound complex of factor IXa and factor VIIIa
Panteleev M. A. - Comparative study of the effect of recombinant factor VIIa on clot growth and thrombin generation in normal and hemophilia A plasma in vitro
Panzer S. - Is inflammation involved in the development of thrombosis in patients with the lupus anticoagulant?
Paoletti F. - A double-blind placebo-controlled randomized study on the efficacy and safety of enoxaparin for the prevention of upper limb deep vein thrombosis in cancer patients with central vein catheter
Paoletti R. - Post-treatment of rats with simvastatin affords brain protection after focal ischemia as assessed by magnetic resonance imaging
Paolucci F. - Two sensitive chromogenic assays of fondaparinux sodium (Arixtra®), a new synthetic and selective inhibitor of factor Xa, in plasma
Pap S. - Identification of amino acids in antiplasmin involved in the noncovalent ‘lysine-binding site’ dependent interaction with plasmin
  - Reversible inactivation of anti-plasmin: evidence for a latent conformation
Papa M. L. - Transdermal hormone replacement therapy does not affect hemostasis and inflammation
Papa R. - Transdermal hormone replacement therapy does not affect hemostasis and inflammation
Papadopoulos A. - Congenital defect of inferior vena cava and thrombophilia Leiden
  - Treatment of DIC: the role of PC
Papagiannaki A. - Left adrenal hemorrhage with intravascular coagulation- case report
Papagrigoriou E. - Crystal structure at 1.7 A of aggretin, a heterodimeric C-type lectin snake venom protein
Papaioannou G. - Thrombophilia and pregnancy
Papakostanti E. - Correlation between SVCAM, SICAM plasma levels, the outcome of treadmill test and the systolic function of left ventricular (LV) in patients with coronary artery disease
Papayan L. - Red blood cells ABH and Lewis antigens prevalence in von Willebrand disease patients
Papayan K. - Molecular risk factors are important causes for the thrombosis in childhood
Paponneau A. - A deficiency of glycoprotein (GP) VI in platelets of a patient with gray platelet syndrome
Paquay M. - Effects of dietary fish oil on coagulation and platelets
Páramo J. A. - Pravastatin modulates the cytokine-induced endothelial expression of PGE2: A novel anti-inflammatory mechanism of cholesterol-lowering drugs
  - Proteolytic pattern in advanced atherosclerotic human lesions: relation to vascular bed, plaque features, and cardiovascular risk factors
  - The endothelial expression of pai-1 by Angiotensin II is dependent on the 4 g/5 g polymorphism: clinical and therapeutic implications
  - Circulating prostaglandin E2 is associated with high risk of coronary heart disease in asymptomatic subjects: a novel inflammatory marker of subclinical atherosclerosis
Parashou S. - Effect of rFVIIa (NovSeven®) on thrombin generation in patients with severe thrombocytopenia
Paraskevopouloy P. - Genetic risk factors in patients with myocardial infarction and correlation with echocardiographic study
Paredes N. - Binding of covalent antithrombin–heparin complex to endothelial cells
Paredes N. - Binding of heparin to alkaline earth and transition metals
Paredes N. - Effect of protein binding on the anti-FXa activity of different heparinoids in either adult or newborn plasma
Parekh H. - A single point mutation of asparagine 511 to serine is responsible for the increased rate of cleavage of high molecular weight in Lewis rat, which is genetically susceptible to inflammatory stimuli
Parente F. - Subcutaneous adjusted-dose unfractionated heparin vs. fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism
Pareyn I. - A new Von Willebrand ristocetin cofactor activity assay based on plasma glycocalicin
  - Desaggregation of ristocetin-induced platelet aggregates by an inhibiting anti-GPIb MoAb
Parfery P. - Combined carrier status of prothrombin 20210 A and factor XIII-A L34 alleles as a strong risk factor for myocardial infarction: evidence of a gene–gene interaction
Parikh N. - The prevalence of, and molecular defects underlying, inherited Protein S deficiency in the general population
Parise P. - A double-blind placebo-controlled randomized study on the efficacy and safety of enoxaparin for the prevention of upper limb deep vein thrombosis in cancer patients with central vein catheter
Parise L. V. - CD47 stimulated sickle erythrocytes adhere to activated monocytes via a novel contribution of the a 4b 1 integrin from each cell type
Parisi R. - Venice DVT
Parisoli A. - Clinical quality assessment program for the oral anti-coagulant clinic: preliminary report of a multicentric Italian exercise
Park H. Y. - Factors that influence the prescribing of low-molecular-weight heparins (LMWHs) in community hospitals: opinions of physicians, clinical pharmacists, and formulary committee members
Park S. - Polymorphisms of 5,10-methylenetetrahydrofolate reductase gene and risk of Korean acute leukemia
  - An analysis of the platelet transcriptome using commercial microarrays
Park Y. - The anti-platelet activity of J78 is mediated mainly by inhibition of arachidonic acid metabolism
Park H. D. - Pharmacokinetics and pharmacodynamics of LB30870, a novel oral low molecular weight direct thrombin inhibitor in healthy volunteers
Park S. - A common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its association with a haplotype in the Korean population
Park S. R. - A common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its association with a haplotype in the Korean population
Parker E. T. - Characterization of high level expression sequence determinants within porcine factor VIII
Parkin D. - Mechanism of activation in Eastern tiger snake bite
Parkos C. A. - Dissociation of the JAM-1/avb3 complex followed by signaling through JAM-1 is key to the angiogenic response induced by bFGF: an explanation of the avb3 paradox
Parmar N. - The effect of age on plasmin generation in the presence of fibrin monomer on endothelium
  - Binding of heparin to alkaline earth and transition metals
Parmar K. - The relationship between APTT and lupus anticoagulants
Parmar N. - Isoform composition of antithrombin (a-AT vs. b-AT) in a covalent antithrombin-heparin complex
  - Effect of heparin on thrombin generation in factor VIII depleted plasma supplemented with FEIBA or FVIII
Parmar K. - The relationship between acute ischemic stroke (AIS) per se and plasma D-D (D-D) levels
  - The relationship between plasma D-dimers (D-d) and thrombus load in patients with deep vein thrombosis (DVT) after acute ischaemic stroke (AIS): a prospective study using magnetic resonance direct thrombus imaging (MRDTI)
  - Performance characteristics of the VIDAS and IL test d-dimer (d-d) assays as exclusionary tests for venous thromboembolism (VTE) after acute ischemic stroke (AIS)
Parmar K. - Validation of the Taipan snake venom assay in routine practice to assess lupus anticoagulant status in patients being assessed for lupus anticoagulant and not receiving oral anticoagulant
Parodi O. - Blood glutathione detects pro-oxidant patterns in mild hyperhomocysteinemia associated with atherothrombotic vascular events
Parodi O. - A new preanalytical procedure using dried blood spot sample for total homocysteine determination
Parolari A. - Platelet-associated Tissue Factor: modulation of cell surface expression by platelet agonists
Parolini M. - A new preanalytical procedure using dried blood spot sample for total homocysteine determination
Parquin F. - Maintenance doses of lepirudin (Refludan), as adjusted by a chromogenic substrate assay (CSA), highly suggest that recommended therapeutical doses should be safely reduced
Parreira A. - A sporadic case of gray platelet syndrome
Parshikov A. V. - Impairment of morphology and NO release in cultured endothelial cells from rabbit coronary vessels following total irradiation by external CO60
Partyka L. - Biochemical fibrinogen modification and atherogenesis
Pascoe G. M. - Increased VWF antigen clearance in partial quantitative von Willebrand factor deficiency and reporting of a familial tendency
Pashov A. - Perturbations in the blood T-cell repertoire of inhibitor-positive patients with severe hemophilia A
Pashov A. D. - Kinetics of hydrolysis by anti-FVIII antibodies in hemophilia A
Pasi J. - In vitro expression of 4 novel mutations identified in type 1 von Willebrand disease patients
  - Co-segregation of Von Willebrands disease type 1 phenotype and Von Willebrand factor gene haplotypes: first results from the multicenter study molecular and clinical markers for the diagnosis and management of type 1 Von Willebrands disease
  - An improved multimeric analysis identifies a subgroup of patients with Type 1 von Willebrand disease characterized by reduced VWF:RCo/Ag ratio
  - Sensitivity and specificity of PFA-100® vs. bleeding time in the diagnosis of type 1 von Willebrand disease (VWD)
  - Molecular and clinical markers for the diagnosis and management of type 1 von Willebrand's disease (VWD): The progress of a European collaboration
  - Mutation analysis in type 1 von Willebrand disease patients entered in the multicenter MCMDM-1VWD study
Pasi K. J. - Two novel mutations in severe factor VII deficiency
Pasi J. - Evaluation of a new quantitative, rapid test (VWF-LIA) for the diagnosis of type 1 VWD
Pasi K. J. - The effects of folic acid supplements on coagulation status in pregnancy
Pasqualini S. - Preconceptional and gestational enoxaparin regimes adjusted to fertility program to prevent preclinical, embryonic and fetal loss in women with Recurrent Pregnancy Loss (RPL) and thrombophilia
Pasquet J. M. - A deficiency of glycoprotein (GP) VI in platelets of a patient with gray platelet syndrome
Passamonti S. M. - Embryo implantation after assisted reproductive procedures and maternal thrombophilia
Passamonti S. - Inherited thrombophilia and hyperhomocysteinemia in upper limb deep vein thrombosis
Passamonti S. M. - High risk of cerebral-vein thrombosis in patients with hyperhomocysteinemia
Passariello A. - Haematologic factors potentially implicated in the pathophysiology of avascular necrosis of the femoral head (AVN): hypercoagulability as a cause of AVN
Pastorelli D. - A comparative study of new generation blood sampling tubes for thrombophilia investigations
  - The effect of two novel plastic citrate tubes (BD Vacutainer Plus): Results in normal subjects and subjects undergoing Unfractionated heparin therapy
Pastorova V. E. - Activation of anti-coagulating system by gelatin introduction to animals
Patel S. - Activated protein C generation is greatly decreased in plasma from newborns compared to adults in the presence or absence of endothelium
Patel H. - Blood transfusion is associated with an enhanced pro angiogenic state
Patel K. C. - Tracking the uptake of evidence: two decades of hospital practice trends for diagnosing deep vein thrombosis and pulmonary embolism
Patel R. - Venous thrombo-embolism in the black population
Patel H. - Low-molecular weight heparin therapy and survival in patients with malignant disease
Patel K. C. - D-dimer for the exclusion of acute deep venous thrombosis and pulmonary embolism: a systematic review
Patel R. K. - Elevated factor VIIIC level is a major risk factor for venous thrombo-embolism in the black population
Pater J. - Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia
Pateyuk A. - Influence of hypophysectomy on hemostasis in chickens
Pathare A. - Burden of von Willebrand disease in India
Patil S. - Opposing effects of P-selectin and PECAM-1 on arterial thrombus growth and stability in vivo
Patrushev L. I. - The role of thrombophilias in the origin of cerebrovascular accidents at the patients with Atrial Fibrillation
Patrushev L. - Factor V Leiden, prothrombin G20210A, and MTHFR C677T gene mutations in patients with primary anti-phospholipid syndrome and cerebrovascular disorder
Patrushev L. I. - Inheritable thrombophilias in women with high risk of obstetric complications in the Moscow population
Patrushev L. - Efficacy of 1-year acenocumarol therapy and its relation with gene polymorphism related to thrombophilia in patients with nonvalvular atrial fibrillation
Patrusheva N. - Efficacy of 1-year acenocumarol therapy and its relation with gene polymorphism related to thrombophilia in patients with nonvalvular atrial fibrillation
  - Factor V Leiden, prothrombin G20210A, and MTHFR C677T gene mutations in patients with primary anti-phospholipid syndrome and cerebrovascular disorder
Pattacini C. - Inferior vena cava filters: personal experience on 322 devices, with regard also to medical treatment during long-term follow-up
  - An alternative model for management of oral anticoagulant therapy: role of general practitioners with support of a computerized system and a portable coagulometer
  - Efficacy of Haemate P in the management of patients with von Willebrand disease undergoing surgery
Pattacini C. - Guidelines on management of nontherapeutic INRs: are really easy to apply in daily practice?
Pattynama P. M. T. - The role of spiral CT in alternative diagnosis in patients with clinical suspicion of pulmonary embolism
Patzke J. - Investigation of plasma related influence factors of a new protein S activity assay (protein S Ac®)
Paul C. - Geographic distribution of asymptomatic constitutional macro thrombocytopenia in Indian subcontinent
Paula E. V. - Evaluation of skeletal muscle perfusion in a hindlimb ischemia model using 99 mTc-sestamibi scintigraphy
Paula E. V. - Alternative second-line treatment for chronic immune thrombocytopenic purpura with sulphasalazine
Pauletto P. - Risk factors for venous thromboembolism in chronically bedridden patients admitted to the Hospice Unit
  - Management of oral anticoagulant therapy in the perioperative period: preliminary results of the application of an operative protocol
Paulin D. - Differential geographic distribution of Factor V Leiden and Factor II Leiden in a French native population (the Fitenat study)
Paulus U. - The efficacy of standard dose vs. 30 mL kg-1 FFP in correcting laboratory parameters of hemostasis in critically ill patients
Pautard B. - Safety and efficacy of Fibrogammin P® for the treatment of patients with severe FXIII deficiency
Pautas E. - Influence of cytochrome P450 2C9 polymorphisms on warfarin maintenance dose in very elderly patients
  - Heparin releasable TFPI Is not depleted after repeated injections of tinzaparin at therapeutic dose for up to 30 days
Pavan P. - Risk factors for venous thromboembolism in chronically bedridden patients admitted to the Hospice Unit
Pavanello R. - A multinational observational cohort study in hospitalized medical patients of practices in prevention of venous thromboembolism and clinical outcomes: findings of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
Pavkovic M. P. - Acquired postpartum hemophilia: report of a case
Pavlova A. - Genetic mechanisms underlying the clinical manifestation of hemophilia A in females
Pavlova A. - Genetic profiling of 20 patients with FVII deficiency by dHPLC and sequence analysis: detection of 7 novel mutations
Pavone G. - Endothelial nitric oxide synthase gene variation and hypertension in pregnancy
Pavord S. R. - The effects of folic acid supplements on coagulation status in pregnancy
Pavord S. - Changes in thromboelastography in low-risk women in the puerperium
Pawar A. - Diagnosis of neonatal alloimmune thrombocytopenic purpura (NAITP) by genotyping and human platelet antigen frequency in the Indian population
Pawlak K. - Interaction between oxidative stress and chemokines in hemodialyzed patients
Pawlak D. - Interaction between oxidative stress and chemokines in hemodialyzed patients
Pawlik A. - A study of gene expression profiles during megakaryocytopoiesis
Pawlinski R. - Role of cardiac myocyte tissue factor in hemostasis in the heart
Pawlinski R. - Role of the tissue factor-thrombin pathway in endotoxemia
Pawlowska Z. - Down-regulation of PAI-1 expression by natriuretic peptides is mediated by MAPK cascade in human endothelial cells
  - The role of vascular endothelial growth factor in an early phases of proangiogenic changes in human endothelial cells
Payne D. A. - Prevention of thromboemboli by enhancing fibrinolysis: a possible therapeutic mechanism of action for Dextran-40
Payne K. - b3 integrin haplotype influences gene regulation
Payne D. A. - The anti-platelet effect of aspirin is reduced following administration of heparin during carotid endarterectomy
Payne N. - Warfarin-resistant factor VII is a potential risk factor for thromboembolism (TE) after prosthetic heart valve replacement
Payrastre B. - Activation of RhoA and Rac through Gq- and G12/G13-mediated pathways in mouse and human platelets stimulated by TXA2 or ADP
  - Lipid rafts in platelet activation processes
Paysant J. - Role of NADPH oxidase on mechanisms implicated in anoxia/reoxygenation-induced leukocyte adhesion to HUVECs
Peña Y. - Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
  - Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Peake I. R. - A novel R2464C candidate von Willebrand factor mutation in families with von Willebrand disease
  - A novel type 1 von Willebrand disease causing mutation (S49R) in the von Willebrand factor pro-peptide that affects von Willebrand factor multimerization and secretion
  - Characterization of mutations in a cohort of type 2 von Willebrand disease patients
Peake I. - An improved multimeric analysis identifies a subgroup of patients with Type 1 von Willebrand disease characterized by reduced VWF:RCo/Ag ratio
  - In vitro expression of 4 novel mutations identified in type 1 von Willebrand disease patients
Peake I. R. - Co-segregation of Von Willebrands disease type 1 phenotype and Von Willebrand factor gene haplotypes: first results from the multicenter study molecular and clinical markers for the diagnosis and management of type 1 Von Willebrands disease
  - Analysis of storage and regulated secretion of three human variants of von Willebrand factor provides new insights into von Willebrand's disease
  - Fluorescent conformation sensitive gel electrophoresis (F-CSGE) analysis of the VWF gene: A high throughput, sensitive mutation detection system
  - Evaluation of a new quantitative, rapid test (VWF-LIA) for the diagnosis of type 1 VWD
  - Can full-length wild-type von Willebrand factor (VWF) or the VWF propeptide rescue secretion of the R273W VWF variant associated with quantitative deficiency?
Peake I. - Molecular and clinical markers for the diagnosis and management of type 1 von Willebrand's disease (VWD): The progress of a European collaboration
Peake I. R. - Sensitivity and specificity of PFA-100® vs. bleeding time in the diagnosis of type 1 von Willebrand disease (VWD)
Peake I. - Mutation analysis in type 1 von Willebrand disease patients entered in the multicenter MCMDM-1VWD study
Pearce A. C. - The peptide LSARLAF causes platelet aggregation through PLCg2 and can induce platelet activation independent of GPIIbIIIa
Pearce A. - A novel pathway of phospholipase Cg2 activation downstream of the platelet integrin aIIbb3
Pearce A. C. - Involvement of the p110d catalytic subunit of phosphatidylinositol 3-kinase in platelet spreading on fibrinogen
Pearson C. - The effect of low and high dose aspirin on the expression of monocyte tissue factor
Pecce R. - Beta-2 integrin adhesion triggered by E-selectin in human PMN: role of SRC kinases and of an unidentified receptor
  - Injection of the inflammatory peptide fMLP in the rabbit induces transient myocardial ischemia: role of thromboxane A2
  - Are daily doses of 80 and 160 mg of aspirin bioequivalent? A pharmacokinetic and pharmacodynamic approach
  - SRC-dependent signaling is a key step in the process of autoregulation of Mac-1 adhesive function in human PMN
Pech C. M. - Coagulation proteases factor Xa and factor VIIa do not mobilize intracellular calcium stores in human dermal fibroblasts
Pecheniuk N. - Neutral and charged lipids in factor Va inactivation
Pecheniuk N. M. - Activated protein C anticoagulant activity mediated by phospholipid vesicles is enhanced by cholesterol and sphingomyelin
Pecka M. - Haemostyptics agents and blood platelet functions
Peder K. - Integrin aVb3 dependent adhesion and spreading under shear stress is particular dependent on the two phenylalanines in the highly conserved GFFKR-region
Pedersen B. - Role of the tissue factor-thrombin pathway in endotoxemia
Pedersen T.M. - Solubilization of CD40L (CD154) from platelets after activation and secretion: proteolysis directly on the platelet surface or after receptor-mediated internalization?
Pedersen B. - Role of cardiac myocyte tissue factor in hemostasis in the heart
Pederson S. - Pharmacokinetics of recombinant human FXIII in cynomolgus monkeys
  - Agreement between FXIII activity assays and calibrator plasma pools: the need for a FXIII reference standard with regulatory recognition
Peebles D. - Reduction in stillbirth and IUGR with aspirin +/- low molecular weight heparin treatment in pregnancy
Peek M. - Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity
Peer N. - Preconceptional, gestational and puerperal low anti-annexin A5 antibody levels in women who develop pre-eclampsia
Peerlinck K. - Deletion of residue Ala2201 in the factor VIII C2 domain impairs FVIII interactions with phospholipids and vWF and results in mild hemophilia A
  - A new Von Willebrand ristocetin cofactor activity assay based on plasma glycocalicin
  - Response to DDAVP in mild/moderate hemophilia A patients according to the underlying factor VIII genotype
Peerschke E. I. B. - Tissue factor pathway inhibitor-2 (TFPI-2) binds the complement and kinin binding protein gC1qR/p33 (gC1qR)
Peeters A. C. T. M. - Homocysteine concentrations are associated with increased t-PA and PAI concentrations in smokers
Peeters M. - Characterization of monoclonal antibodies that inhibit either the activation of proCPU (TAFI) or the activity of CPU (TAFIa)
Pegoraro C. - Symptomatic chronic thromboembolic pulmonary hypertension after symptomatic pulmonary embolism: incidence and risk factors: a long-term follow-up study
Peine S. - Sensitivity of platelet retention test Homburg (RTH) in drug monitoring and measuring vs. Willebrand factor–mediated platelet adhesiveness
Peiretti F. - Transmembrane TNFa and wild-type TNFa differently modulate atherosclerotic process in mice
Pejhan N. - Identification of intron 1 and 22 inversion mutation in the factor VIII gene of 94 Iranian families with hemophilia A
Pellati D. - Plasma fibrinolytic capacity and 4G/5G polymorphism of PAI-1 gene in heart and kidney transplant recipients with or without steroid immunosuppression
  - Pseudogene coamplification mimicking a 14-bp deletion mutation in exon 5 of plasminogen gene: a methodological study
Pellequer J. L. - A novel engineered interdomain disulfide bond stabilizes human blood coagulation factor VIIIa
Penas N. - Replacement therapy for surgery and delivery in three patients from a single family with R1374C type 2M von Willebrand disease (VWD): the role of PFA100 monitoring
Penas N. - A new candidate mutation (C1272S) in type 2 A von Willebrand disease (VWD) affecting the disulfide loop responsible for the interaction of von Willebrand factor (VWF) with platelet glycoprotein Ib-IX
Pencreach E. - Cross-talk between alpha2beta1 integrin and GPVI receptors regulates actin polymerization through Rho GTPase and MAP kinase Erk1/2 signaling pathways in human megakaryocytes
Pendry K. - Management of pulmonary embolism: Can we consider outpatient treatment?
Peng Y. W. - Compound 48/80 inhibits thrombosis in balloon-injured arteries of hypercholesterolemic rabbits by inhibiting TF/FVIIa-mediated coagulation
Peng H. - Structural basis for differences in heparin-dependence of endothelial cell proliferative activities of human FGF-1 and FGF-2
Peng W. - Trp2063 and Trp2064 in the factor V C2 domain are required for factor Va binding to phospholipid membranes but not for assembly of the prothrombinase complex
  - Tyr1956 and Leu1957 in the factor V C1-domain are required for high affinity binding of factor Va to phospholipid membranes
Pengo V. - Symptomatic chronic thromboembolic pulmonary hypertension after symptomatic pulmonary embolism: incidence and risk factors: a long-term follow-up study
  - Perioperative management with low molecular weight heparin (LMWH) of patients (pts) on long-term oral anticoagulant therapy (OAT) undergoing major surgery: a multicenter prospective observational study
Penka M. - Multi-diagnostic retrospective study of risk factors of thrombosis in children with cancer – is there a space for multivariate predictive modeling?
  - rFVIIa NovoSeven®– Hemostatic agent not only for hemophiliacs
  - Risk of venous thromboembolism during pregnancy and puerperium in women with homozygous form of F V Leiden
PENNANEAC'H C. - A study of 10 rapid d-dimer tests for the exclusion of acute venous thromboembolism
Pennings A. - Higher reticulated platelet counts and enhanced expression of P-selectin in patients with immune thrombocytopenic purpura compared to patients with myelodysplastic syndromes
Pentimone A. - Identification of a dysfibrinogenemia characterized by marked resistance to fibrinolysis in an asymptomatic woman
Penttila A. - Kozak sequence polymorphism of the platelet glycoprotein Ibalpha gene and Thr789Ala polymorphism of the von Willebrand factor gene in fatal CAD
Pepe G. - Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal transplant recipients
  - Inhibition of human neutrophils plasminogen activation by elastase-derived apolipoprotein(a) fragments
  - Protein Z levels in acute coronary syndromes
  - Optimization of human 14 000 oligonucleotide-microarrays and study design for the evaluation of gene expression profiling in cardiovascular diseases
  - Hemostatic changes in laparoscopic and laparotomic gynecological surgery
Pepperell J. C. T. - Increased circulating cardiovascular risk factors in obstructive sleep apnoea and the effect of CPAP therapy
Pepperkok R. - Intracellular trafficking of native, full-length, and B-domain-deleted coagulation factor VIII (FVIII) in mammalian cells
Perdriset G. - Does DVT exist in Asia? – The AIDA study (assessment of the incidence of Deep Vein Thrombosis in Asia following major orthopedic surgery): study rationale and interim results
Perdue J. J. - Long-term outcomes following recovery from thrombotic thrombocytopenic purpura – hemolytic uremic syndrome (TTP-HUS) measured by health-related quality-of-life (QOL) assessments
Pereira R. - Non-Hodgkin's lymphoma and antiphospholipid antibodies. Are they surrogate markers for relapse?
Pereira J. - Comparison of template bleeding time and PFA-100 as screening tests in 175 consecutive patients with hereditary mucocutaneous hemorrhages (MCH)
Pereira P. - A different view on the inflammatory bowel disease – the role of adhesion molecules and angiogenic growth factors
Pereira C. - A different view on the inflammatory bowel disease – the role of adhesion molecules and angiogenic growth factors
Pereira I. - Coagulation inhibitor monitoring rationale in critical patients with severe sepsis
Pereira J. - Lack of association of platelet membrane glycoprotein polymorphisms with the clinical expression of von Willebrand disease type 1
Pereira M. E. - Lack of association of platelet membrane glycoprotein polymorphisms with the clinical expression of von Willebrand disease type 1
Pereira J. - Patients with mild hereditary bleeding disorders have normal thrombin generation (TGPPP) in platelet poor plasma
Pereira R. - Effects of cardiopulmonary bypass on platelet activation markers
Pereira C. - Association of MTHFR and ACE gene polymorphisms in reflux associated with renal damage
Perera A. - Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
  - Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Peretz H. - The molecular basis of Glanzmann thrombasthenia in Arabs
Perez A. - Replacement therapy for surgery and delivery in three patients from a single family with R1374C type 2M von Willebrand disease (VWD): the role of PFA100 monitoring
Perez Y. - Two sensitive chromogenic assays of fondaparinux sodium (Arixtra®), a new synthetic and selective inhibitor of factor Xa, in plasma
Perez A. - A new candidate mutation (C1272S) in type 2 A von Willebrand disease (VWD) affecting the disulfide loop responsible for the interaction of von Willebrand factor (VWF) with platelet glycoprotein Ib-IX
Pérez R. - Interferon and ribavirin in patients with chronic hepatitis C and congenital bleeding disorders
  - Natural history of hepatitis C infection in hemophilia patients at Hospital Universitario Virgen del Rocío (Sevilla, Spain)
Perez-Casal M. - Detection of Thrombomodulin (TM) Ala455Val polymorphism using sequence-specific primer–polymerase chain reaction (PCR) in patients with severe obstetric complications
Pérez-Ceballos E. - Analysis of the HPS-1 gene in patients with single platelet dense-granule deficiency and mild bleeding diathesis
Perez-Montes R. - Successful use of recombinant FVIIa (Novoseven) for severe bleeding in a patient undergoing bone marrow transplantation refractory to standard hemostatic support
  - Recombinant Factor VIIa as hemostatic agent in acquired von Willebrand disease
Pérez-Pujol S. - Stored platelets contain residual amounts of tissue factor
Pérez-Requejo J. - Clopidogrel inhibits collagen-induced platelet recruitment in whole blood
  - Aspirin resistance: to screen or not to screen?
Pérez-Riba M. - PROS1 mutations that introduce a premature termination codon explain protein S deficiency by nonsense-mediated mRNA decay
Pergantou H. - Thrombosis in Neonates and children at various sites (1999–2002): thrombophilic factors, recurrence and outcome
Pergantou H. - Von Willebrand disease: a bleeding disorder increasingly recognized over the recent years
Perin A. D. - Prothrombin mutation G20210A, and not factor V Leiden, is a significant risk factor for cerebral venous thrombosis in 27 Brazilian patients
Perkins S. J. - Factor X Cardiff and Factor X Newcastle: Two new FX mutations associated with low activity and antigen levels
Perneby C. - Clopidogrel treatment provides limited protection against exercise-induced platelet-leukocyte conjugation
Perneby C. - Clopidogrel treatment reduces platelet activity in vivo, but does not counteract exercise-induced platelet activation
Perneger T. V. - Antiphospholipid/antiprotein antibodies and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case–control study
Pernod G. - Safety and efficacy of Fibrogammin P® for the treatment of patients with severe FXIII deficiency
Pernod G. - High-level transgene expression of lentivirus-transduced human endothelial cells
Pernollet M. G. - Intravenous immunoglobulins G modulate calcium signals, von Willebrand factor secretion and nitric oxide metabolism in human endothelial cells
Perola M. - Kozak sequence polymorphism of the platelet glycoprotein Ibalpha gene and Thr789Ala polymorphism of the von Willebrand factor gene in fatal CAD
Perricaudet M. - The anti-angiogenic effect of endostatin is associated to a direct effect on the tumor growth in colon cancer
Perrier A. - Diagnosing pulmonary embolism with clinical assessment, d-dimer, venous ultrasound and helical computed tomography: a multicenter management study
  - Clinical usefulness of D-dimer in cancer patients with suspected pulmonary embolism
  - Clinical usefulness of D-dimer according to clinical probability in patients with suspected pulmonary embolism
Perrin L. A. - The Gas6 receptors Axl, Sky, and Mer function to enhance human platelet degranulation and aggregation
Perrotta P.L. - Human blood platelets: RNA transcript profiling using microarray and serial analysis of gene expression
Perry D. - DRVVT testing for lupus identification: a comparison of two methods
Perry D. J. - Use of TEG® as a global measure of thrombogenicity in thrombophilia screening
Persaud K. - Poor correlation between aPTT, anti-Xa levels and heparin dose in children receiving therapeutic doses of unfractionated heparin
Persson E. - L305V/S314E/K337A/F374Y-Factor VIIa has dramatically enhanced intrinsic activity
Persson E. - Variants of rFVlla with increased intrinsic activity
  - Enhanced procoagulant and antifibrinolytic potential of superactive variants of recombinant factor VIIa in plasma from patients with severe haemophilia A
  - Hemostatic effect of three factor VIIa analogs in antibody-induced hemophilia A in mice
Pescatore S. - Phase I study of a novel recombinant human soluble thrombomodulin, ART-123
Pesman G. - IL-6 concentration in the acute phase of deep-vein thrombosis is a strong predictor of elevated venous outflow resistance as a proxy of post-trombotic syndrome
Pestana M. - Association of MTHFR and ACE gene polymorphisms in reflux associated with renal damage
Pestina T. I. - aIIbb3 activation by botrocetin/vWf is ADP or TXA2 dependent and the resulting aIIbb3 outside-in signaling is the major trigger for subsequent granule release and TXA2 production
Peter U. - Treatment of recurrent arterial thrombosis with hirudin in congenital afibrinogenaemia
Peter K. - Integrin aVb3 dependent adhesion and spreading under shear stress is particular dependent on the two phenylalanines in the highly conserved GFFKR-region
Peter K. H. - Human, conformation-specific, anti-GPIIb/IIIa (aIIbb3) single-chain antibodies generated by differential phage-display: a new generation of platelet inhibitors specific for the activated GPIIb/IIIa receptor?
Peter K. - Construction and characterization of a new recombinant plasminogen activator composed of an antifibrin single-chain antibody and a low molecular weight form single-chain urokinase
  - The Jarvik 2000 artificial heart does not affect the activation status of platelets
Peterlin B. - The frequencies of fibrinogen polymorphisms Taq I, Hae III and Bcl I in patients with deep-vein thrombosis
Peternel P. - Safety of the transfer of patients on anticoagulant therapy from hospital anticoagulant clinics to general practitioners using a computer-decision support
Peters M. - The development and evaluation of a quality of life questionnaire for children with hemophilia
  - The clinical outcome of pediatric venous thrombo-embolic disease in one tertiary centre
  - Impact of knowledge of a positive family history on the clinical presentation of hemophilia
Peters G. - Rates of recurrent thromboembolism and bleeding in venous thromboembolism patients treated with long-term LMWH
Peters M. - Protein C activation and possible use in different disease states - Necrotizing enterocolitis
Peters F. - Fatal pulmonary embolism in medical patients
Peters M. - Mortality of Dutch hemophilia patients, a prospective follow-up of 973 patients, 1992–2002
Peters G. R. - Randomized, double-blind comparison of ximelagatran, an oral direct thrombin inhibitor, and warfarin to prevent venous thromboembolism (VTE) after total knee replacement (TKR)
Peters R. J. G. - Clopidogrel suppresses rebound coagulation after discontinuation of enoxaparin treatment in patients with acute coronary syndromes
  - Recombinant factor VIIa reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteers
Peters M. - An evaluation of 30 years of hemophilia treatment in the Netherlands
  - Incidence and risk factors for factor VIII antibodies in mild hemophilia A
Petersen L. C. - Anti-apoptotic effect of coagulation factor VIIa
Peterson J. A. - Integrin clustering mechanisms explored with a soluble aIIbb3 ectodomain construct
Peterson M. - Reliability of patient self-testing and point-of-care testing with the Harmony (TM) INR monitoring system: a 3-year study
Peterson J. T. - The Gas6 receptors Axl, Sky, and Mer function to enhance human platelet degranulation and aggregation
Peterson J. A. - Maternal immunization against ‘rare’ platelet antigens as a cause of neonatal alloimmune thrombocytopenic purpura (NATP)
Peterson M. - Maintenance of patient vs. professional competence with patient self testing of the INR – a 6-year experience
Petitou M. - Effect of anticoagulants with various modes of action on thrombin generation in plasma of mice with targeted Arg47-to-Cys mutation of the heparin-binding domain of antithrombin
  - Antithrombin-mediated inhibition of factor IXa by synthetic oligosaccharides
Petrescu C. A. M. - Evaluation of the rFVIIa efficacy in children's haemorrhages of different etiology
Petrescu C. A. M. - Medical and surgical approach of pseudotumours and blood cysts in hemophiliacs without primary prophylactic replacement therapy
Petrini P. - Hand computer and Internet for collection and presentation of patient diary data in a Nordic clinical multicenter safety surveillance study of ReFacto®
Petrini P. - Determination of overall hemostasis potential in different coagulation factors deficient plasma and in plasma samples from patients with hemophilia A and B
Petris U. - Contemporary total hip and knee replacement in A patients with haemophilia and high titre of inhibitors to FVIII by using recombinant FVIIa (novoseven) continuous infusion
Petrobelli F. - Atherosclerosis as a potential risk factor of venous thrombosis
Petros S. - Platelet mediated thrombin generation depends on F VIII and Factor IX in a complex way: evidences for the Cell-based model of hemostasis
  - The influence of the prothrombin mutation 20210 GA and the level of prothrombin on the thrombin generation
  - GP IIb-IIIa antagonists and thrombin generation
Petrov V. Y. - Idiopathic thrombocytopenic purpura at children, associated with a virus of rubella
Petrov V. Y. - The principles of therapy of hemorrhagic vasculitis at children
Petrov V. V. - Plasma glycocalicin level in diagnosis of the idiopathic thrombocytopenic purpura (ITP) in children
Petrov V. Y. - Cases of development of an idiopathic thrombocytopenic purpura at children associated with introduction of a tuberculin
Petrovan R. J. - Tissue factor pathway inhibitor-2 (TFPI-2) binds the complement and kinin binding protein gC1qR/p33 (gC1qR)
Petruzziello T. - Autoantibodies to recombinant PSI domain but not to cytoplasmic tail of beta3 integrin cause immune thrombocytopenia
Petterson T. M. - Familial segregation of venous thromboembolism
  - Genetic susceptibility of venous thromboembolism: role of the procoagulant, anticoagulant, fibrinolytic, and acute inflammation pathways
Pettilä V. - Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin
Peynet J. - Response to DDAVP in mild/moderate hemophilia A patients according to the underlying factor VIII genotype
Peyvandi F. - Allelic heterogeneity of severe factor V deficiency: doubling of the mutational spectrum of the factor V gene, and expression of the identified missense mutations
Peyvandi F. - In vitro expression study of four single nucleotide polymorphisms in the ADAMTS13 gene
Peyvandi F. - A naturally homozygous deletion mutation of LYS9 or LYS10 in the A-chain of alpha-thrombin reduces the catalytic efficiency of the enzyme
  - Lack of association between the annexin V gene -1C®T polymorphism and acute myocardial infarction in 150 young Italian women
  - Analysis of the molecular mechanism of factor VII (FVII) deficiency caused by IVS2 + 1 donor splice sites mutation by ‘Exon Trapping System’ technique
  - Functional characterization of a naturally occurring homozygous Gly25Ser mutation in thrombin B chain
Peyvandi F. - A 3' untranslated region (3' UTR) variation on the factor VII (FVII) gene changes completely the phenotype due to the Arg277Cys mutation in a patient with Type I FVII deficiency
Peyvandi F. - Congenital afibrinogenemia, identification of four novel homozygous mutations in the fibrinogen gene cluster: three point mutations and a 15-kb deletion
  - In vitro expression study of two naturally occurring mutations (D141Y and C275S) of the von Willebrand factor (VWF) proeptide that result in defective multimerization and secretion
  - Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS-13 von Willebrand factor cleaving protease)
Peyvandi P. - Prenatal diagnosis of dysprothrombinemia in an Iranian family
Peyvandi F. - A study of 130 Italian patients on anti-coagulant treatment: how variant alleles of gene CYP2C9 influence requirement dose of warfarin during the induction period of treatment
Peyvandi F. - Mild ADAMTS-13 deficiency in patients with ischemic stroke
  - Analysis of 100 Iranian patients with factor XIII (sub unit A) deficiency
Pfliegler G. - Anti-phospholipid syndrome during pregnancy: only the high-dose of LMWH thromboprophylaxis is successful
  - The role of platelet concentrate in the treatment of von Willebrand's disease
Pfliegler G. Y. - Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding
Phelps M. A. - Familial segregation of venous thromboembolism
Philip I. - a2b1 density and a2 polymorphisms in coronary artery disease
Philipp C. S. - Treatment and management of women with bleeding disorders and menorrhagia (WBDM) study: study design and characteristics of women enrolled
Philippe C. - Prevention of wine consumption on thrombosis but not on atherosclerosis in ApoE-/- mice
Philippou H. - Roles of low specificity and cofactor interaction sites on thrombin during factor XIII activation: competition for cofactor sites on thrombin determines its fate
  - Impaired interaction of protein C Gla domain variants with the endothelial cell protein C receptor (EPCR)
Philips M. - Development of inhibitors against factor VII in patient with severe factor VII deficiency
Phillips D. R. - Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis
  - CD84 signaling is a novel platelet stimulatory mechanism that occurs during platelet aggregation
  - Platelet activation causes a metalloprotease-mediated down-regulation of GlycoproteinVI
  - P2Y12 regulates platelet adhesion/activation, thrombus growth and thrombus stability in injured arteries
Piñol M. - New automated von Willebrand factor activity assay to distinguish type 1 and type 2 von Willebrand disease (VWD)
Piñón M. - Platelet–erythrocyte interactions enhance GPIIbIIIa receptor activation and P-selectin expression during platelet recruitment. These effects are amplified in type I diabetic patients
  - Insufficient thromboxane A2 inhibition in patients with vascular disease chronically treated with aspirin: implications for platelet function
Piana R. N. - Chronic paclitaxel exposure increases human endothelial expression of plasminogen activator inhibitor-1, tissue-type plasminogen activator and tissue inhibitor of metalloproteinase-1
Piatkowska E. - Regulation of gene expression in huvec and human umbilical progenitor CD 34+ cells by VEGF, bFGF and PPARg agonist
Picard V. - Anti-thrombin F229L: a new homozygous variant leading to spontaneous anti-thrombin polymerization in vivo and severe childhood thrombosis
Picard F. - Human platelet microparticles shedding is independent of the Cdc42/Rac1/PAK Pathway
Piccapietra B. - Factor V Leiden mutation (FV:Q506): A new functional screening assay with 100% specificity and sensitivity
Piccardoni P. - Beta-2 integrin adhesion triggered by E-selectin in human PMN: role of SRC kinases and of an unidentified receptor
  - SRC-dependent signaling is a key step in the process of autoregulation of Mac-1 adhesive function in human PMN
Piccinatto C. E. - A 23-bp insertion in the EPCR gene and the risk of venous thrombosis
  - A transcobalamin gene polymorphism and the risk of deep venous thrombosis
Piccioli A. - Subsequent diagnosis of malignancy in patients presenting with an idiopathic venous thromboembolism – a number needed to screen and decision analysis based on the results of a prospective study
  - The long-term clinical course of acute deep vein thrombosis of the arm: a prospective cohort study
Piccioni F. - Enhanced TNF-a and oxidative stress in patients with heart failure: effect of TNF-a on platelet O2 production
Piccoli A. - SRC-dependent signaling is a key step in the process of autoregulation of Mac-1 adhesive function in human PMN
Piccoli E. - Intruterine Growth Restriction (IUGR) and thrombophilic polymorphisms
Piccoli A. - Beta-2 integrin adhesion triggered by E-selectin in human PMN: role of SRC kinases and of an unidentified receptor
Pickering W. - The use of phospholipid-dependent clotting assays to characterize the cell-surface procoagulant activities of T-lymphoblastoid cell lines
  - Basal levels of phosphatidylserine exposure on the cell-surface of T-lymphoblastoid and monocytoid cells: relationship to Prothrombin and FX activation, and Tissue Factor activity
Piegsa K. - Activated protein C resistance (APCR) and combined oral contraceptives: acquired APCR is more pronounced in women receiving desogestrel containing COCs than those containing levonorgestrel and is associated with low protein S levels
Pieniaszek H. - A pharmacokinetic study of tinzaparin in pediatric patients
Pieragnoli P. - Angiotensin converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation
Pieralli M. - Monitoring of heparin therapy during cardiopulmonary bypass by using three different devices that measure the activated clotting time
  - Monitoring of heparin therapy during cardiopulmonary bypass by using three different devices that measure the activated clotting time
Pieralli F. - Long-term clinical outcome of patients with pulmonary embolism: a prospective, multicenter study
Pierangeli S. S. - Intracellular events in antiphospholipid-mediated platelet activation
Pierangeli S. S. - Inhibitors of NFkB and p38 kinase abrogate tissue factor up-regulation by anti-phospholipid antibodies
Pierangeli S. - Effects of fluvastatin on up-regulation of tissue factor by antiphospholipid antibodies
Pierce G. - A phase I/II trial of AAV-mediated, liver-directed gene transfer for hemophilia B
Pierce J. M. T. - Does thromboelastography demonstrate hypercoagulability in patients with both a clinical history of thrombosis and the lupus anti-coagulant antibody?
Pieroni G. - Arterial ischemic stroke (AIS) in children: a prospective 10-year registry in Argentina
  - Venous thromboembolism (VTE) in children: A prospective 10-year registry in Argentina
  - Biological and clinical DDAVP response in children with von Willebrand disease (VWD)
  - Cerebral sinovenous thrombosis (SVT) in children: a prospective 10-year registry in Argentina
Pierri S. - Retrospective study of acquired factor VIII inhibitor
  - Association between recurrent pregnancy loss and prothrombotic gene polymorphisms
Piersma M. - Individual variations of the level of oral anticoagulation in patients with venous thromboembolism (VTE) as predictor of clinical outcome
Pieters M. - The effect of refined and red palm olein compared to sunflower oil on lipids and homeostatic factors in hyperfibrinogenemic patients
Pietila K. - Relation of prothrombotic platelet polymorphisms to the first manifestation of Coronary Artery Disease in middle-aged males
Pietrucha T. - Polymorphisms of the factor VII gene and ischemic stroke in young adults
Piffath C. - Inhibition of metalloproteases during platelet storage leads to better platelet recovery and improved platelet function upon transfusion
Pignatelli P. - Antioxidant effect of wine in human: role of polyphenols
Pignatelli P. - Increased platelet superoxide anion production in patients with hypertension: role of AT1 receptors
  - Aggregometric evidence of a progressive reduction of platelet sensitivity to aspirin
  - A polyphenol mixture inhibits collagen induced platelet aggregation
Pignatelli P. - Enhanced TNF-a and oxidative stress in patients with heart failure: effect of TNF-a on platelet O2 production
Pignoloni P. - Thrombophilic screening in patients with paroxysmal nocturnal hemoglobinuria
Pikovski I. - Cytoskeletal regulation of the adhesive interactions between the platelet GPIb/V/IX receptor and von Willebrand factor
Pilarska E. - Thrombophilic risk factors of ischemic stroke in children
Pillarisetti K. - Potentiation of aggregation through the stimulation of platelet P2X1 receptors
Pillow A. G. - Legg-Perthe's disease and thrombophilia: a causal association?
Pilsgaard B. - Prolonged thromboprophylaxis with low molecular weight heparin (dalteparin) after major abdominal surgery: the FAME study
Pimanda J. - The control of von Willebrand Factor multimer size by thrombospondin-1
Pindur G. - Thrombophilia – from the roots to the base of evidence. Preliminary results on platelet function and rheologic parameters and the necessity of prospective multicentre cohort trials
  - On the role of platelets, and homocysteine in thrombotic patients, healthy controls and mutant carriers of methylentetrahydrofolate reductase (‘MTHFR’) (C677T)
Pineda J. - Pharmacogenetics in the thrombolytic treatment of myocardial infarction: role of the FXIII V34L polymorphism
  - Myocardial infarction in young patients: risk factors and thrombophilia study
Pinedo H. M. - Venous thrombosis in cancer patients: insights from the FRONTLINE survey
Pinel C. - The effect of orally administered heparins on a rat carotid arterial model of thrombosis
Pineo G. F. - Timing of initial administration of prophylaxis against deep vein thrombosis in patients following hip or knee surgery
  - Does rebound exist? A comparison of venous thromboembolic event rates in the post-treatment period for patients randomized to long-term low-molecular-weight heparin vs. warfarin sodium
  - Oral SNAC-heparin vs. enoxaparin for preventing venous thromboembolism following total hip replacement
  - A randomized trial evaluating long-term low-molecular-weight heparin therapy for three months vs. intravenous heparin followed by warfarin sodium in patients with current cancer
  - A randomized trial evaluating long-term low-molecular-weight heparin therapy for three months versus intravenous heparin followed by Warfarin Sodium
Ping L. F. - Alteration of the KGD sequence in fibrinogen b-chain slowed platelet mediated clot retraction
Pinho N. - Coagulation inhibitor monitoring rationale in critical patients with severe sepsis
Pini M. - Diagnosis of deep vein thrombosis in hospitalized elderly patients: poor discriminant value of clinical pretest probability unless integrated by d-dimer assay
Pini M. - A multinational observational cohort study in hospitalized medical patients of practices in prevention of venous thromboembolism and clinical outcomes: findings of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
  - Low molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anti-coagulants
Pino M. - Hemostatic effect of activated recombinant factor VII (rFVIIa) in liver disease: studies in an in vitro model
Pinotti M. - Enhanced thrombin generation and mild bleeding tendency in a severely FVII-deficient patient carrying FV Leiden
Pinotti M. - Impaired prothrombinase activity of Factor X Gly381Asp results in severe familial CRM + FX deficiency
  - Heterogeneous molecular pattern of Factor VII deficiency associated to cerebral hemorrhage
Pinsky D. J. - CD39 ecto-nucleotidase activity (metabolizing ATP to ADP to AMP) constitutes a homeostatic mechanism for control of platelet reactivity, depending on the ratio of ADPase to ATPase activity. Results from patients with coronary artery disease
Pintão M. C. T. - Factor XIII (FXIII) Val34Leu, His95Arg and G30899A polymorphisms and the risk of deep venous thrombosis
Pinter E. - Matrix, protease and angiogenesis
Piovella F. - Oral anticoagulation telemedicine management system: the MC-SAT project
Piovella C. - Oral anticoagulation telemedicine management system: the MC-SAT project
Piovella F. - Incidence of newly diagnosed cancer after three months or one year of oral anticoagulation for a first episode of idiopathic venous thromboembolism
  - Long-term clinical outcome of patients with pulmonary embolism: a prospective, multicenter study
Piovella F. - Does DVT exist in Asia? – The AIDA study (assessment of the incidence of Deep Vein Thrombosis in Asia following major orthopedic surgery): study rationale and interim results
Piovella F. - A multinational observational cohort study in hospitalized medical patients of practices in prevention of venous thromboembolism and clinical outcomes: findings of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
Pipe S. W. - Genetic modifications that increase factor VIII secretion in vitro and in vivo
Pipe S. - The mutation Ser2117Leu, in the second hydrophobic spike of the factor V C2 domain, increases phospholipid affinity and specific activity
Pipe S. W. - MCFD2, a second gene defective in combined factor V/factor VIII deficiency, encodes a novel ER protein that interacts with LMAN1 (ERGIC-53) to form a cofactor-specific sorting receptor
Piper C. - The G allele of IL-6–174G/C polymorphism is a risk factor for restenosis after coronary stent implantation by increased inflammation and platelet activation
  - Influence of platelet glycoprotein IIIa PlA polymorphism on mean platelet volume and vWF after coronary stent implantation
Piquer D. - Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitor
Piquet P. - Maintenance doses of lepirudin (Refludan), as adjusted by a chromogenic substrate assay (CSA), highly suggest that recommended therapeutical doses should be safely reduced
Piquet P. - Hiruquant®, a new simple and quick assay for monitoring of hirudin therapy
Piquinela M. - Association between recurrent pregnancy loss and prothrombotic gene polymorphisms
Piro D. - Identification of a dysfibrinogenemia characterized by marked resistance to fibrinolysis in an asymptomatic woman
Piso B. - The impact of interassay-variations in the International Normalized Ratio on dosing oral anti-coagulants
Pisu G. - Fasting homocysteine levels in predicting post methionine loading test results
Pisu G. - G20210A prothrombin mutation and allele 4G of gene PAI-1 in deep vein thrombosis
Pitcher L. - Correction of coagulation, as measured by the thromboelastogram, with low dose recombinant VIIa treatment in a patient with a factor VIII inhibitor
Pitchford S. - Platelet depletion abolishes eosinophil recruitment to the lungs and tissue remodelling in an allergic asthma model in mice
Pithara E. - Treatment of DIC: the role of PC
  - Sticky platelet syndrome
  - Factor VIII inhibitor in a patient with multiple sclerosis and interferon regimen
Pittendreigh C. - The effect of selective serotonin reuptake inhibitor anti-depressants on platelets
Pixley R. - A single point mutation of asparagine 511 to serine is responsible for the increased rate of cleavage of high molecular weight in Lewis rat, which is genetically susceptible to inflammatory stimuli
Pizzey A. - Expression of prion protein (PrPC) in the megakaryocyte lineage
Pizzi C. - Reduced platelet sensitivity to nitric oxide donors in patients with a history of preeclampsia
Pizzolo F. - Factor VII polymorphisms and the risk of myocardial infarction in coronary atherosclerosis
  - Low vitamin B6, markers of inflammation, and coronary artery disease
Plahuta T. G. - The experience of treatment of children with hemostasis system pathology treatment with recombinant factor VII NovoSeven
  - Using NovoSeven (NS) – recombinant factor VIIa to control the bleedings in Bernard-Soulier (BSS) girl. Case report
Plahuta T. G. - The principles of therapy of hemorrhagic vasculitis at children
Plahuta V. Y. - Idiopathic thrombocytopenic purpura at children, associated with a virus of rubella
Plahuta T. G. - Cases of development of an idiopathic thrombocytopenic purpura at children associated with introduction of a tuberculin
Plaimauer B. - ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS-13
  - Towards the development of a recombinant von Willebrand factor-cleaving protease (ADAMTS-13)
Plaisance S. - Establishing links between coagulation and inflammation: The lectin-like domain of thrombomodulin confers protection in a murine model of rheumatoid arthritis
  - Deficiency in one Gas6 receptor (Axl, Sky or Mer) protects mice against thrombosis because of a platelet dysfunction
Planes A. - Evaluating bleeding complications of thromboprophylaxis after hip replacement: a systematic review
  - Does DVT exist in Asia? – The AIDA study (assessment of the incidence of Deep Vein Thrombosis in Asia following major orthopedic surgery): study rationale and interim results
Plank C. - Fibrinogen – a new tool for gene delivery
  - Magnetofection – a highly efficient tool for endothelial gene transfer and antisense oligonucleotide delivery in vitro and in vivo
Plank D. M. - Identification of a tissue factor ortholog in zebrafish, a potential new animal model of hemostasis and cancer
Plantavid M. - Lipid rafts in platelet activation processes
  - Activation of RhoA and Rac through Gq- and G12/G13-mediated pathways in mouse and human platelets stimulated by TXA2 or ADP
Plantier J. L. - Human factor IX expression in megakaryocytes derived from electrophorated human hematopoietic cells
Platokouki H. - Thrombosis in Neonates and children at various sites (1999–2002): thrombophilic factors, recurrence and outcome
  - Von Willebrand disease: a bleeding disorder increasingly recognized over the recent years
Plesch W. - Equivalence of venous and capillary INR values determined with the new CoaguChek® PT.S-test on the CoaguChek® S system
Plesch W. - Performance evaluation of the new CoaguChek® PT.S-test on the CoaguChek® S system
Ploos Van Amstel J. K. - The relation between clinical phenotype and genotype of severe hemophilia A
Ploumidis L. - Smoking and abnormalities of coagulation-fibrinolysis in patients with coronary heart disease
  - Correlation SVCAM, SICAM plasma levels with the outcome of treadmill test and with attitudinal factors for coronary artery disease in patients without previous history of ischemic heart disease
  - Is there an hypercoagulable state after treadmill exercise in patients with atrial fibrillation?
Plu-Bureau G. - Oral not transdermal estrogen replacement therapy is associated with venous thromboembolism risk
Plug I. - Mortality of Dutch hemophilia patients, a prospective follow-up of 973 patients, 1992–2002
Plug I. - The development and evaluation of a quality of life questionnaire for children with hemophilia
Plug I. - An evaluation of 30 years of hemophilia treatment in the Netherlands
Plyusch O. P. - Home treatment of patients with hemophilia in Russia
Plyusch O. P. - Results of clinical use of ‘NovoSeven’ in Russia
Plyushch O. P. - Comparative study of the effect of recombinant factor VIIa on clot growth and thrombin generation in normal and hemophilia A plasma in vitro
Podda G. - Does plasma homocysteine influence the in vitro anti-coagulant response to activated Protein C?
Podda M. - P-selectin-dependent lung colonization of melanoma cells is targeted by heparin treatment
Podorolskaya L. V. - Thrombolytic action of longolytin – product of low fungi Arthrobotrys longa in rabbit thrombosis model
Poetzsch B. - Tissue factor (TF) gene expression analysis in blood monocytes
  - Use of aprotinin as an antidote in activated protein C related bleeding
  - Anti-endothelial cell antibodies (AECA): cDNA-based antigen screening
Poetzsch B. - Induction of monocytic tissue factor (TF) expression: an additional mechanism of action of desmopressine acetate (DDAVP)
Poetzsch B. - Gene expression analysis in platelets: use of a PCR-based RNA amplification technique for generating suitable amounts of cDNA
Poggi M. - Risk of recurrence of venous thromboembolism (VTE) and high factor VIII plasma levels
Poggini L. - Hemophilia in pediatrics: clinical experience in a single hemophilia center
Poggio R. - Long-term clinical outcome of patients with pulmonary embolism: a prospective, multicenter study
  - Incidence of newly diagnosed cancer after three months or one year of oral anticoagulation for a first episode of idiopathic venous thromboembolism
Pogliani E. - Incidence of newly diagnosed cancer after three months or one year of oral anticoagulation for a first episode of idiopathic venous thromboembolism
  - Long-term clinical outcome of patients with pulmonary embolism: a prospective, multicenter study
Pohl U. - Magnetofection – a highly efficient tool for endothelial gene transfer and antisense oligonucleotide delivery in vitro and in vivo
Pohl C. - The risk of heparin-induced thrombocytopenia and the frequency of heparin-dependent antibodies in neurologic patients treated with unfractionated heparin
Pohl U. - A cytochrome P450 2C8/9-derived EDHF inhibits platelet adhesion to endothelial cells in vitro
Pokrovskaya E. - Changes of hemostatic parameters in patients with non-ST elevation acute coronary syndrome treated with atorvastatin or pravastatin (randomized comparative study)
Pol D. - Elevated factor VIII: a possible link between periodontal disease and acute coronary syndrome
Polack B. - High-level transgene expression of lentivirus-transduced human endothelial cells
Polak J. F. - C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the Cardiovascular Health Study (CHS)
Polanowska-Grabowska R.K. - Autophosphorylation of focal adhesion kinase at Tyr397 in collagen-stimulated human platelets
Polanowska-Grabowska R. - Shiga toxin interactions with platelets: differential effects of anti-coagulants and platelet isolation procedures
  - Hypochlorous acid-oxidized LDL rapidly induces platelet aggregation in the presence of low levels of ADP, thrombin, epinephrine and chemokines
Poli D. - Homocysteine plasma levels in primary biliary cirrhosis (PBC)
  - Genetic variants of CYP2C9 cytochrome do not account for high intraindividual variability of patients in their response to oral anti-coagulants (OA): a collaborative controlled study
Poli D. - Hyperhomocysteinemia as a risk factor for TIA and stroke in patients with AF
  - Rate of adverse events during OAT in patients with mechanical prosthetic heart valves replacement
Polidano E. - Evidence for extracellular signal-regulated kinase 1/2 activation by thrombin that is independent on epidermal growth factor receptor transactivation in vascular smooth muscle cells
Poll R. G. - Thromboprophylaxis in orthopedic surgery: Clinical practice in the Netherlands
Pollars D. A. - Combined modality inhibitor eradication in a patient with mild hemophilia A and comparison of methods of inhibitor monitoring
Pollefety S. - Endothelial-specific inactivation of survivin in mice results in embryonic lethality with intraembryonic bleeding due to loss of vascular endothelial integrity
Poller L. - European concerted action on anti-coagulation (ECAA). Correction of displayed INR on two point-of-care test (POCT) whole blood prothrombin time monitors (CoaguChek Mini and TAS PT-NC) by independent International Sensitivity Index (ISI) calibration
  - European action on anti-coagulation – cost effectiveness of computer assisted anti-coagulant dosage
Poller L. - European concerted action on anti-coagulation (ECAA). reliability of International Normalized Ratios (INR) from CoaguChek mini and TAS PT-NC whole blood point-of-care test monitor systems
Pollmann C. - Molecular genetic analysis of gene variants in the 5' flanking region of the FVII gene: Identification of a novel mutation in a German family
Pollmann H. - Assessment of the inhibitor development in previously untreated patients (PUPs) suffering from hemophilia A treated with rFVIII: continuous evaluation of the German Pharmacovigilance Evaluation (PE) with ReFacto & reg
Pollmann H. - Prophylactic treatment of afibrinogenemia with the fibrinogen concentrate Haemocomplettan®
  - The development of inhibitors directed against factor VIII after continuous infusion of factor VIII concentrates in patients with hemophilia A
  - Evaluation of a ‘handheld’ communicator based electronic system for documentation of hemophilia A and B therapy in home-care settings
Polo S. - Coagulation inhibitor monitoring rationale in critical patients with severe sepsis
Polo A. B. - Deep venous thrombosis of the arm: comparison of sulodexide and acenocoumarol for the secondary prevention of venous thromboembolism
Polo S. - The prognostic value of platelet count drop in an intensive care unit
Polus A. - Biochemical fibrinogen modification and atherogenesis
  - Regulation of gene expression in huvec and human umbilical progenitor CD 34+ cells by VEGF, bFGF and PPARg agonist
Pombodakis C. - Comparison and diagnostic value of two different D-dimer methods in the clinical laboratory
Ponce R. - Pharmacokinetics of recombinant human FXIII in cynomolgus monkeys
Poncelet P. - Immuno-phenotypic platelet characteristics distinguish high vs. low risk patients for thrombosis after stent implantation under thienopyridin plus aspirin treatment
Poncelet P. - A dedicated system for standardized measurement of VASP phosphorylation in blood platelets and detection of thienopyridine resistance
Poncz M. - Transgenic mice studies demonstrate a role for platelet factor 4 (PF4) in thrombosis: implications for heparin-induced thrombocytopenia (HIT)
Poncz M. - A transgenic mouse model demonstrates the efficacy of Factor VIII ectopically expressed in platelets for Haemophilia A treatment
  - Gene targeting of platelets
Poncz M. - PF4 and heparin form high molecular weight complexes that is central to the pathogenesis of Heparin-Induced Thrombocytopenia
Poncz M. - A novel platelet-specific delivery system for fibrinolytic agents
Poncz M. - Murine (m) aIIb out-competes human (h) aIIb for mouse b3 in a transgenic mouse model: Implications for integrin subunit interactions
Ponde C. K. - Elevated factor VIII: a possible link between periodontal disease and acute coronary syndrome
Pongthanapisith V. - The use of recombinant activated factor VII for controlling life-threatening bleeding in dengue shock syndrome
Pons C. - A dedicated system for standardized measurement of VASP phosphorylation in blood platelets and detection of thienopyridine resistance
Pontara E. - Interaction of factor VIII and von Willebrand factor investigated in a large cohort of von Willebrand disease patients: evaluation of the type 2N variant prevalence
Pontiggia L. - Blockade of GPIIb/IIIa by abciximab, eptifibatide and tirofiban at high shear results in a differential inhibition of platelet aggregation, platelet microparticle formation and phosphatidylserine exposure
Pooga M. - Inhibition of FVIII coagulation activity by FVIII-light-chain-specific antibodies of haemophilia A patient
Poole A. W. - Physical and functional interaction between PKCd and Fyn kinases in human platelets
Poole A. W. - P2Y1 signaling through Src tyrosine kinase in human platelets
Poole A. W. - Regulation of tyrosine phosphatase SHP-1 in human platelets by protein kinase C
Poon K. S. V. - Senescent rabbit platelets, or rabbit platelets with experimentally shortened survival, are apoptotic with increased surface exposure of procoagulant phosphatidylserine (PS)
Popoff S. N. - Regulation of connective tissue growth factor (CTGF) in synovial lining and modulation of the disease course of acute arthritis in an experimental model of rheumatoid arthritis by residues D793-P824 derived from thrombospondin-1-type 3 repeats
  - Connective tissue growth factor (CTGF) expression in synovial lining is down regulated by residues D793-P824 derived from thrombospondin-1 type-3 repeats (TSP1) in an experimental animal model of rheumatoid arthritis
Popova L. - The role of thrombophilia in the development of atherothrombosis in diabetes mellitus
Popovic V. - Premature atherosclerosis in adult growth hormone deficiency: interaction of fibrinolytic and metabolic factors
Popovic B. - Improving bridge-out therapy with low-molecular-weight heparin in an urban, inner city medical center
Porciani M. C. - Angiotensin converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation
Porro F. - Incidence of newly diagnosed cancer after three months or one year of oral anticoagulation for a first episode of idiopathic venous thromboembolism
  - Long-term clinical outcome of patients with pulmonary embolism: a prospective, multicenter study
Porta C. - Objective assessment of deep vein thrombosis and pulmonary embolism can be deferred without increased risk of thrombosis: a practical approach based on the pretest clinical model, d-dimer and the use of low molecular weight heparins
Porta B. - A case of multiorgan atherosclerotic disease in patient affected by hyperhomocystinemia with multiple heterozygous mutations
Porte A. - Frequency and effects of cytochrome P450 2C9 polymorphisms in 61 patients treated by warfarin
Posadas-Romero C. - Lipoprotein (a) polymorphisms in Mexican-Amerindian populations
Pósán E. - The role of platelet concentrate in the treatment of von Willebrand's disease
Posan E. - Anti-phospholipid syndrome during pregnancy: only the high-dose of LMWH thromboprophylaxis is successful
Pospisil C. H. - gA/g' fibrin affords thrombin greater protection from inhibition by the heparin/antithrombin complex than gA/gA fibrin
Potoczak R. - Compound 48/80 inhibits thrombosis in balloon-injured arteries of hypercholesterolemic rabbits by inhibiting TF/FVIIa-mediated coagulation
Potron G. - Increasing the dosage of aspirin before percutaneaous coronary intervention: is there any effect in aspirin resistant patients? A randomized study
  - Platelet function peculiarities throughout childhood: a flow cytometric study from healthy premature new-borns up to 15-year-old-children
Poulios N. - Development of economic and outcomes model of hemophilia treatment in Latin America and South-east Asia
Poulios N. S. - Economic evaluation of anti-D immunoglobulin in the treatment of immune thrombocytopenic purpura in adults in the United Kingdom
Poulios N. - Economic modeling of full-length anti-hemophilic factor (recombinant), plasma/albumin-free method (rAHF-PFM), vs. B-domain deleted rFVIII (BDDrFVIII) in previously treated patients (PTPs) with hemophilia A
Pouliot R. L. - Phenotypic thrombin generation: a composite view
Poulsen L. H. - Whole blood coagulation profiles in patients with thrombosis
Poulsen L. H. - Phenotypic variation in real-time whole blood clot formation profiles in severe hemophilia. Response patterns following ex vivo addition of rFVIII and rFIX
Pound M. L. - Sensitivity and specificity of the abnormal optical waveform profile in the prothrombin time from patients with antiphospholipid antibodies
  - Inhibition of factor VIII binding to phospholipids by single-chain variable domain fragments indicates that F2200 plays a more important role than M2199 in membrane-binding
Pouplard C. - Changes in the platelet count (PC) after cardiopulmonary bypass (CPB) can efficiently predict the development of pathogenic heparin- dependent antibodies (Abs)
Pouwels J. G. - Thrombopoietin increases platelet adhesion and decreases rolling to von Willebrand factor
Pouzol P. - A retrospective evaluation of the use of B-domain deleted recombinant Factor VIII (ReFacto®) administered by continuous infusion during surgical procedures
  - Safety and efficacy of Fibrogammin P® for the treatment of patients with severe FXIII deficiency
Powell J. - Pharmacokinetics of functional von Willebrand Factor (VWF) with infusion of Koate-DVI® in patients with von Willebrand's Disease (VWD)
Powers M. R. - Inhibition of retinal neovascularization in mice by antisense phosphorodiamidate morpholino oligomer against av integrins
Poyarkova S. - Secondary stereoselectivity of enzymes with a strictly specific action
Poyarkova S. A. - Synthesis of arginine-containing peptides and study on their effects upon thrombin
Pozner R. G. - Characterization of the von Willebrand factor present in circulating PMN
  - Prostacyclin protects basal and nitric oxide-induced megakaryocytes apoptosis
Pozzi S. - Elevated plasma levels of factor VIII in women with early recurrent miscarriage
  - Reduced platelet sensitivity to nitric oxide donors in patients with a history of preeclampsia
Pradella P. - Crucial role of the ADP receptor P2Y1 in platelet adhesion and signaling under high flow
Pradier A. - Investigations on the regulation of vascular smooth muscle cell migration by tissue factor (CD142)
  - The influence of tissue factor (CD142) on endothelial cell apoptosis and proliferation
Prager G. W. - Urokinase receptor (uPAR) regulates integrin redistribution during initial vascular endothelial growth factor (VEGF)-induced endothelial cell migration
Prandoni P. - Management of hospitalized patients with suspected deep vein thrombosis
  - Subsequent diagnosis of malignancy in patients presenting with an idiopathic venous thromboembolism – a number needed to screen and decision analysis based on the results of a prospective study
  - The incidence of venous thromboembolism in double-heterozygous carriers of antithrombin, protein C and protein S deficiency and HR2 haplotype
  - The incidence of venous thromboembolism in homozygous or double heterozygous carriers of the factor V Leiden mutation, prothrombin 20210 A mutation and HR2 aplotype: interim report
  - Subcutaneous adjusted-dose unfractionated heparin vs. fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism
  - The incidence of venous thromboembolism in carriers of single identified prothrombin G20210A: a retrospective cohort study
Prandoni P. - Below-knee elastic compression stockings for prevention of the post–thrombotic syndrome in patients with proximal-vein thrombosis: a prospective controlled randomized study
Prandoni P. - Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT study): interim report of prospective randomized study
  - Incidence of newly diagnosed cancer after three months or one year of oral anticoagulation for a first episode of idiopathic venous thromboembolism
  - The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study
  - Symptomatic chronic thromboembolic pulmonary hypertension after symptomatic pulmonary embolism: incidence and risk factors: a long-term follow-up study
  - Long-term clinical outcome of patients with pulmonary embolism: a prospective, multicenter study
  - The long-term clinical course of acute deep vein thrombosis of the arm: a prospective cohort study
Prandoni P. - Atherosclerosis as a potential risk factor of venous thrombosis
Prandoni P. - Medical and cancer patients - who is at risk of VTE?
  - Foundations of clinical practice - Treatment of venous thromboembolism
Prasa D. - A rapid chromogenic method for determination of TAFI in plasma samples
Prasad R. N. V. - Coagulation and fibrinolysis during the menstrual cycle and the effects of increased body mass index
Prasad U. K. - Plasma leptin is associated with hemostatic cardiovascular risk factors
Prati P. - Association between fibrinogen levels and fibrinogen G-455 A polymorphism and preclinical atherosclerosis in the general population
Pratnicka M. - High frequency of combined genetic prothrombotic defects in young patients with ischemic stroke
Pratt K. P. - Recombinant factor VIII C1C2 domain expressed in E. coli
Praus M. - Recombinant PrPP102L stimulates t-PA mediated plasminogen activation 4-fold stronger than recombinant wild-type PrPc
Prechel M. M. - Activation of neutrophils by antibodies generated in heparin-induced thrombocytopenia
Prechel M. M. - Activation of platelets by HIT antibodies in vitro is not dependent on the presence of heparin
Prechel M. M. - Heparin-induced anti-platelet antibodies in very low birth-weight infants
Prechel M. M. - A postoperative platelet count threshold contributes to an earlier diagnosis of heparin-induced thrombocytopenia and improved platelet recovery in cardiac surgery patients. The HITME (Heparin-Induced Thrombocytopenia Multicenter Evaluation) study
Prechel M. - Reviparin normalizes tissue factor pathway activation in patients with lower limb immobilization and is not associated with heparin antibody production
Prechel M. M. - Intimatan ameliorates the activation of human platelets by heparin/heparin antibody from patients with heparin-induced thrombocytopenia
Prechel M. - Lower limb trauma is associated with a moderate risk of thrombosis caused by sustained release of tissue factor despite early functional mobilization
Preece N. - Transport of blood samples through a pneumatic tube system causes loss of platelet function
Preissner K. T. - An intracellular cofactor of Factor VII activating protease (FSAP) functions as an initiator of blood coagulation
  - Factor VII activating protease is an inhibitor of platelet derived growth factor-BB-mediated migratory and mitogenic activities on vascular cells
Preissner K. - Microvesicle and platelet associated tissue factor promote initiation of coagulation
Preissner K. T. - Regulation of neovascularization by a-defensins: a link between inflammation and angiogenesis
Preloznik-Zupan I. - Utility of in vitro closure time (PFA-100TM) for evaluating platelet related primary hemostasis in dialysis patients
Preston F. E. - Possible causes of variation in INR results in UK NEQAS EQA program for Near Patient Testing/Point of Care devices
  - Diagnosis of factor XIII deficiency – room for improvement? Experience with the UK NEQAS (Blood Coagulation) proficiency testing programme
  - Results of d-dimer in the UK NEQAS (Blood Coagulation) proficiency testing program: Urgent need for improvements in Standardization of testing and reporting
Preston R. - Impaired interaction of protein C Gla domain variants with the endothelial cell protein C receptor (EPCR)
Preston F. E. - Von Willebrand factor measurement in the UK NEQAS proficiency testing program
  - Use of SSC/ISTH secondary standard to evaluate laboratory performance: A UK NEQAS for blood coagulation proficiency testing exercise
Preston F. E. - Accuracy of laboratory diagnosis of familial thrombophilia, 2001–2002: UK NEQAS experience
Preston F. E. - Use of plasma spiked with monoclonal antibodies in lupus anticoagulant (LA) screening; experience with the UK NEQAS (Blood Coagulation) proficiency testing program
  - Incidence of venous thrombosis in carriers of familial thrombophilia with a personal history of venous thrombosis
Preston F. E. - SSC classification of hemophilia A: is it achievable? A UKNEQAS supplementary exercise
Preston F. E. - Artificially depleted plasmas are suitable for proficiency testing of INR determination with some POC devices
Preston E. - An evaluation of four methods of external quality assurance (EQA) for patient self-management (PSM) of oral anti-coagulation: report on 97 patients
Prestwich G. D. - Lipid Phosphate Phosphatase 1 (LPP1) regulates lysophosphatidic acid signaling in platelets
Pretelli P. - Monitoring of heparin therapy during cardiopulmonary bypass by using three different devices that measure the activated clotting time
  - Monitoring of heparin therapy during cardiopulmonary bypass by using three different devices that measure the activated clotting time
Preusser Tiede M. - Life-threatening thrombosis following splenectomy in a patient with ITP: successful management with anticoagulation and danazol
Prevost N. - Contact-dependant signalling during late events of platelet activation
Prevost D. - Crystal structure of benzamidine-Factor VIIa/soluble tissue factor at 1.87 Å resolution: mapping of calcium, magnesium, sodium, and zinc sites in the Factor VIIa structure
Price C. - C-reactive protein (CRP) may predict death from cancer in men with lower extremity arterial disease
Price P. - Limited exposure of phosphatidylserine on stimulated platelets is necessary for procoagulant activity and provides binding sites for lactadherin
Price V. - Central venous catheter (CVC) related thrombosis in boys with hemophilia
Price P. - The mutation Ser2117Leu, in the second hydrophobic spike of the factor V C2 domain, increases phospholipid affinity and specific activity
Price C. - The predictive value of C-reactive protein (CRP) for myocardial infarction may be affected by aspirin therapy in men with lower extremity arterial disease
Prieto C. - Lack of association of platelet membrane glycoprotein polymorphisms with the clinical expression of von Willebrand disease type 1
Primoziè R. - Comparison of a computer-based dosing program ‘Trombo’ with a manual dosing to monitor anti-coagulant therapy
Princen T. W. M. - Potential reversal agents for the long-acting pentasaccharide idraparinux
Princen H. M. G. - Decrease of thrombophilia variables by aggressive vs. conventional atorvastatin treatment in patients with type 2 diabetes mellitus
  - Atorvastatin strongly reduces C-reactive protein, but shows less marked effect on other prognostic inflammatory markers
Príncipe F. - Non-Hodgkin's lymphoma and antiphospholipid antibodies. Are they surrogate markers for relapse?
Princivalle M. - Anticoagulant heparan sulfate proteoglycans in mammalian reproductive function
Prins M. H. - Atherosclerosis as a potential risk factor of venous thrombosis
  - The long-term clinical course of acute deep vein thrombosis of the arm: a prospective cohort study
  - The risk of pregnancy complications in women from families with thrombophilic defects
  - Symptomatic chronic thromboembolic pulmonary hypertension after symptomatic pulmonary embolism: incidence and risk factors: a long-term follow-up study
Prins M. - Long-term treatment with dalteparin low-molecular-weight heparin (LMWH) may improve survival in patients with nonmetastatic malignancy and venous thromboembolism (VTE)
  - Long-term treatment with dalteparin low-molecular-weight heparin (LMWH) is more effective than oral anticoagulant (OA) therapy in cancer patients with venous thromboembolism (VTE)
Prins M. H. - Risk assessment of venous thromboembolism in pregnant women with factor V Leiden, prothrombin 20210 A mutation, elevated factor VIII levels or mild hyperhomocystinaemia
  - Absolute risk of venous thromboembolism (VTE) associated with a single or combined thrombophilic disorder. Preliminary results of a family cohort study
  - Absolute risk of venous and arterial thromboembolism associated with mild hyperhomocysteinemia. Preliminary results of a family cohort study
  - Venous and arterial thromboembolic risk in first degree family members of patients with elevated plasma levels of clotting factor VIII:c
  - The balance between the benefits and risks of treatment with vitamin K antagonists as perceived by patients
  - Increased risk for venous thromboembolism and myocardial infarction in family members of patients with prothrombin 20210 A mutation
  - Local changes in coagulation and fibrinolysis in patients with a previous deep venous thrombosis
  - Below-knee elastic compression stockings for prevention of the post–thrombotic syndrome in patients with proximal-vein thrombosis: a prospective controlled randomized study
  - The optimal duration of treatment with vitamin K antagonists in patients with a first episode of venous thromboembolism: a decision analytic approach
  - Patients' valuation of outcomes after venous thromboembolism
  - Subsequent diagnosis of malignancy in patients presenting with an idiopathic venous thromboembolism – a number needed to screen and decision analysis based on the results of a prospective study
  - Definitions of the post–thrombotic syndrome: a comparison with invasive venous pressure measurement
  - Relation between compliance and quality of treatment with vitamin K antagonists
Prinzen L. - Function of calcium-dependent protein kinase C in platelet aggregation and thrombus formation: Studies using a chemically synthesized TAT-linked peptide blocking the C2 domain of protein kinase C-beta
Prisco D. - Increased lipoprotein(a) levels as an independent risk factor for idiopathic and recurrent venous thrombosis
  - Genetic variants of CYP2C9 cytochrome do not account for high intraindividual variability of patients in their response to oral anti-coagulants (OA): a collaborative controlled study
  - TAFI plasma levels are not increased in ischemic heart disease patients admitted to a coronary care unit
  - Perioperative management with low molecular weight heparin (LMWH) of patients (pts) on long-term oral anticoagulant therapy (OAT) undergoing major surgery: a multicenter prospective observational study
  - Hemostatic changes in laparoscopic and laparotomic gynecological surgery
  - Genetically defined protein S (PS) deficiency is associated with venous thrombosis
  - Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal transplant recipients
  - Rate of adverse events during OAT in patients with mechanical prosthetic heart valves replacement
  - Protein Z levels in acute coronary syndromes
  - Evaluation of the fibrinolytic capacity before and after venous occlusion performed by serum d-dimer test after standardized coagulation
  - Hyperhomocysteinemia as a risk factor for TIA and stroke in patients with AF
  - Monitoring of heparin therapy during cardiopulmonary bypass by using three different devices that measure the activated clotting time
  - Monitoring of heparin therapy during cardiopulmonary bypass by using three different devices that measure the activated clotting time
  - Assessment of platelet function during cardiopulmonary bypass using two new "point of care" devices
Prism Trial Investigators  - Prolonged thromboprophylaxis with low molecular weight heparin (tinzaparin) following major general surgery primarily for cancer: An individual patient data meta-analysis
Pritchard S. - Severe factor VII deficiency caused by a new point mutation combined with a previously undetected gene deletion
Procaccini D. - Occurrence of myocardial infarction and PAI-1 4G/5G and ACE I/D gene polymorphisms in patients on chronic dialysis
Procházka M. - Coagulation factor V Leiden not increased in pregnancies complicated by abruptio placentae
Procopciuc L. - Genetic thrombophilia in Romanian women with pregnancy loss and pre-eclampsia
Prostredna M. - Targeting of the collagen binding site on glycoprotein VI is not essential for in vivo depletion of the receptor
PROTEKT INVESTIGATORS¶  - Central venous line-related thrombotic events in children: association with duration of line placement, type, size, and location
Proulle V. - A new evidence of a relationship between store-operated calcium entry and the regulation of procoagulant phosphatidylserine exposure at the surface of stimulated cells
Proulle V. - The coordinated transcription of genes encoding regulators of cell cycle progression revealed by expression profiling upon calcium ionophore A23187 treatment of B lymphoblasts from a patient with Scott syndrome
Proulle V. - The role of the ATP-Binding Cassette transporter A1 (ABCA1) in phosphatidylserine cell surface exposure and in the modulation of the procoagulant phenotype
Prybyla D. - Concomitant use of mechanical and pharmacological methods of prophylaxis for venous thromboembolism after total hip and knee arthroplasty: Findings from the Global Orthopaedic Registry (GLORY)
Pryjma J. - Sialic acid and lipid contents of low density lipoprotein in relation to platelet receptor activity
Psaty B. M. - C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the Cardiovascular Health Study (CHS)
  - Intracellular adhesion molecule-1 is associated with cardiovascular disease in elderly men and women
Puchades Y. - Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
  - Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Pudore L. - Transdermal hormone replacement therapy does not affect hemostasis and inflammation
Puga L. M. - Increased levels of endothelial injury marker in close relationship with lipoatrophy in HIV infected patients under high active antiretroviral treatment
  - Insulin resistance status and truncal fat are important determinants of plasminogen activator inhibitor type-1 (PAI-1) levels in HIV infected patients
Pujol-Moix C. - Analysis of the HPS-1 gene in patients with single platelet dense-granule deficiency and mild bleeding diathesis
Pujol-Moix N. - Transmission electron microscopy of granulocyte inclusions in genetically confirmed MYH9-related disorders
Pulcinelli F. M. - A polyphenol mixture inhibits collagen induced platelet aggregation
Pulcinelli F. - Aggregometric evidence of a progressive reduction of platelet sensitivity to aspirin
Pulcinelli F. M. - cAMP inhibits convulxin-induced calcium mobilization; differences with collagen
  - Enhanced TNF-a and oxidative stress in patients with heart failure: effect of TNF-a on platelet O2 production
  - Antioxidant effect of wine in human: role of polyphenols
Purdy G. - A novel r-polypeptide, kunitz-type inhibitor with high specificity for plasma kallikrein and potential for therapeutic use
  - The effect of pathogen inactivation treatment processes on VWF cleaving protease, VWF:Ag and protein S levels in blood components used in therapeutic plasma exchange for thrombotic thrombocytopenic purpura
  - A multicentre assessment of the endogenous thrombin potential using a continuous monitoring amidolytic technique
Purusuthoman V. - Critical lower limb ischemia caused by essential thrombocytosis and successful limb salvage using angiographic-guided intra-arterial thrombolysis with rTPA
Purvis A. - Characterization of a mixed disulfide intermediate between the propeptide and the mature subunit of von Willebrand Factor during multimer formation
Pütz B. - Clinical manifestations of the antiphospholipid syndrome in patients with highly elevated anticardiolipin antibodies
  - The antiphospholipid syndrome and cerebral manifestations
Pyke C. - In vitro effect of recombinant activated factor VII on thrombin generation and clot formation in blood from patients on vitamin K-antagonist therapy
  - Hemostatic effect of three factor VIIa analogs in antibody-induced hemophilia A in mice
  - Hemostatic effect of rFVIIa (NovoSeven®) in a mouse model of type 1 von Willebrand disease (VWD)
Pyle M. - The relationship between the TNF-308 polymorphism and Legg-Perthes disease
Pyo H. - Inhibitory mechanism of rat aortic vascular smooth muscle cell proliferation by NQ12, a novel antithrombotic agent